Equity Overview
Price & Market Data
Price: $20.22
Daily Change: -$0.43 / 2.13%
Range: $20.17 - $20.98
Market Cap: $0
Volume: 45,657
Performance Metrics
1 Week: 3.27%
1 Month: 12.77%
3 Months: -0.25%
6 Months: -25.99%
1 Year: -24.71%
YTD: -15.55%
Details
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.